Impact of Dietary Fibre Consumption on Digestive Comfort
NCT ID: NCT05830032
Last Updated: 2023-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
12 participants
INTERVENTIONAL
2022-10-01
2023-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Dietary Fibres on Metabolic Health and the Gut Microbiome
NCT06580132
Dietary Fibers Effect on the Gut Microbiota Composition
NCT04114513
Gastrointestinal Toleration of Inulin Products
NCT00958529
Investigation of the Effects of Dietary Fibres on the Gut Microbiome in a Transgenerational Cohort
NCT05364437
Impact of Native Chicory Inulin on Change and Persistence of Gut Microbiota
NCT06528041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to investigate the impact different fibres have on gastrointestinal symptoms when they are consumed individually or as mixtures and how this relates to the composition of the stool.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Soluble Corn fibre
Soluble corn fibre (SCF) (15g fibre/day)
Soluble corn fibre
As a powdered beverage
Inulin
Inulin (In) (15g fibre/day)
Inulin
As a powdered beverage
Soluble corn fibre and inulin
SCF + In (15g/day fibre)
soluble corn fibre and inulin
As a powdered beverage
Control (Maltodextrin)
Control (Maltodextrin) (0g fibre)
Maltodextrin
As a powdered beverage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soluble corn fibre
As a powdered beverage
Inulin
As a powdered beverage
soluble corn fibre and inulin
As a powdered beverage
Maltodextrin
As a powdered beverage
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-smokers
Exclusion Criteria
* Individuals who are pregnant or are trying to get pregnant
* Individuals with any food allergies
* Individuals who have taken antibiotics in the past 3 months
* Individuals who regularly take medication that may modify gastrointestinal function e.g. prokinetic agents (e.g. metoclopramide), antiemetics, constipation treatments (e.g. lactulose, polyethylene glycol)
* Individuals who consume ≥25g fibre per day
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mondelēz International, Inc.
INDUSTRY
University of Glasgow
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christine Edwards
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christine A Edwards, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Glasgow
Ada L Garcia, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Glasgow
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Nutrition New Lister Building
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP/2294514
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.